Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Eddy Blinker who wrote (1947)	12/22/1999 5:22:00 AM
From: Mike M	Read Replies (3) \| Respond to of 5582

Sold my GUMM because I could not see the urgency for GUMM to render 49% against a $10 million investment from uncle Carl in Sweden if GUMM presently has a hot product flying out the stores and earning millions of bucks in America. What does the nicotine agreement have to do with Zicam? GUMM has simply entered into another business and will enjoy 49% of the proceeds of that business without any extraordinary capital expenditure. They did not dilute one share of stock yet they have 49% ownership of a new company immediately valued at $10M. The nicotine market is huge and GUMM has a worthy partner for overseas and domestic distribution. This allows instant marketing muscle as well as access to overseas distribution channels. Moreover, it doesn't take anything away from the Gel Tech business. You are welcome to sell your shares but I think your reasoning is circumspect.